Journal of Pediatric Perspectives

Journal of Pediatric Perspectives

Lymphopenia and Acute Kidney Injury in Pediatric COVID-19: Mortality Focus Abstract

Document Type : original article

Authors
1 Department of Pediatric Nephrology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
2 Department of Community Medicine, Faculty of Medicine, Sabzevar University of Medical Sciences, Khorasan Razavi, Iran.
3 Student of Medical Sciences, Zahedan University of Medical Sciences, Zahedan, Iran.
4 Department of Pediatrics, Children and Adolescent Health Center, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
5 Department of Pediatric Nephrology, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Khorasan Razavi, Iran.
10.22038/jpp.2026.98822.5734
Abstract
Background: Acute kidney injury (AKI) is a serious complication in adults with Coronavirus disease 2019 (COVID-19). While lymphopenia indicates disease severity, its association with renal outcomes in pediatric COVID-19 remains unclear. This study compared AKI incidence, severity, and prognosis between lymphopenic and non-lymphopenic children hospitalized with COVID-19.
Methods: In this retrospective cohort study, medical records of children under five years (n=148) hospitalized with PCR-confirmed COVID-19 were reviewed. Patients were divided into lymphopenic (n=35) and non-lymphopenic (n=113) groups based on admission absolute lymphocyte count. AKI severity was classified using the Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Data were analyzed using SPSS 25 with Chi-square, Mann-Whitney U, Fisher's exact tests, and multiple logistic regression.
Results: Overall AKI incidence was 9.5% (14/148). The lymphopenic group was significantly younger (P=0.031). AKI incidence was higher in the lymphopenic group (14.3%) than in the non-lymphopenic group (8.0%), but not significantly (P=0.321). No significant differences were found in AKI severity (P=0.627) or prognosis (P=1.000). Multiple regression showed lymphopenia, age, sex, and comorbidities were not independent predictors of AKI. Notably, mortality in children who developed AKI was alarmingly high (35.7%) compared to those without AKI (5.2%).
Conclusion: Although lymphopenia was not a significant predictor of AKI in this pediatric cohort, the strikingly high mortality associated with AKI underscores the critical need for rigorous renal function monitoring in all hospitalized children with COVID-19.
Keywords
Subjects

1. Florez H, Singh S. Online dashboard and data analysis approach for assessing COVID-19 case and death data. F1000Research. 2020 Jun 8;9:570.
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020 Feb 15;395(10223):497-506.
3. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020 Jun 1;145(6):e20200702.
4. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MB, et al. Multisystem inflammatory syndrome in US children and adolescents. New England Journal of Medicine. 2020 Jul 23;383(4):334-46.
5. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international. 2020 May 1;97(5):829-38.
6. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney international. 2020 Jul 1;98(1):209-18.
7. Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2?. American Journal of Physiology-Renal Physiology. 2020 Jun 1;318(6):F1454-62.
8. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy. 2020 Mar 27;5(1):33.
9. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cellular & molecular immunology. 2020 May;17(5):533-5.
10. Wu Y, Hou B, Liu J, Chen Y, Zhong P. Risk factors associated with long-term hospitalization in patients with COVID-19: a single-centered, retrospective study. Frontiers in Medicine. 2020 Jun 9;7:315.
11. Santos H, Delpino F, Veloso O, Freire J, Gomes E, Pereira C. High Neutrophil-lymphocyte Ratio Is a Prognostic Marker for Mortality in Severe Covid-19 and Is Associated With Elevated Age and Kidney Failure.
12. Wagner J, DuPont A, Larson S, Cash B, Farooq A. Absolute lymphocyte count is a prognostic marker in Covid‐19: a retrospective cohort review. International journal of laboratory hematology. 2020 Dec;42(6):761-5.
13. Geme JW. Nelson textbook of pediatrics. Elsevier; 2020.
14. US Department of Health and Human Services. National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 5.0. 2017 [Internet]. 2023
15. Maranhão MC, Mateus MD, Tosatto GS, Pangracio É, Schreiner GZ, Olandoski KP, et al. Acute kidney injury: a post-COVID-19 complication in children and adolescents. Revista Paulista de Pediatria. 2025;43:e2023171.
16. Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Annals of medicine. 2020 Oct 2;52(7):345-53.
17. Basiratnia M, Derakhshan D, Yeganeh BS, Derakhshan A. Acute necrotizing glomerulonephritis associated with COVID-19 infection: report of two pediatric cases. Pediatric Nephrology. 2021 Apr;36(4):1019-23.
18. Abdelkareem M, Hargas A, El Attar M, Ahmed S, Atia F. Frequency and clinical characteristics of kidney involvement in children with suspected COVID-19 infection: a single-center cross-sectional study. Egyptian Pediatric Association Gazette. 2025 Sep 5;73(1):80.
19. Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta paediatrica. 2020 Jun;109(6):1088-95.
20. Andreu-Ballester JC, Pons-Castillo A, González-Sánchez A, Llombart-Cussac A, Cano MJ, Cuéllar C. Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality. PLoS One. 2021 Aug 13;16(8):e0256205.
21. Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clinical Chemistry and Laboratory Medicine (CCLM). 2020 Jun 25;58(7):1135-8.
22. Mohkam M, Mirzaee M, Abdollah GF, Rafiei TS, Karimi A, Armin S, et al. Renal involvement in COVID-19 among Iranian children.
23. Wang D, Gao Y, Lai QQ, Wu D, Liu HY, Meng H, et al. Dynamic lymphocyte-CRP ratio as a predictor: a single-centre retrospective study on disease severity and progression in adult COVID-19 patients. Journal of International Medical Research. 2024 Mar;52(3):03000605241236278.